van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360(15):1500–8. https://doi.org/10.1056/NEJMoa0808718.
Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360(15):1518–25. https://doi.org/10.1056/NEJMoa0808949.
Kajimura S, Saito M. A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol. 2014;76:225–49. https://doi.org/10.1146/annurev-physiol-021113-170252.
Cohen P, Kajimura S. The cellular and functional complexity of thermogenic fat. Nat Rev Mol Cell Biol. 2021;22(6):393–409. https://doi.org/10.1038/s41580-021-00350-0.
Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009;58(7):1526–31. https://doi.org/10.2337/db09-0530.
Matsushita M, Yoneshiro T, Aita S, Kameya T, Sugie H, Saito M. Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int J Obes (Lond). 2014;38(6):812–7. https://doi.org/10.1038/ijo.2013.206.
Chondronikola M, Volpi E, Borsheim E, Porter C, Annamalai P, Enerback S, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63(12):4089–99. https://doi.org/10.2337/db14-0746.
Yoneshiro T, Aita S, Matsushita M, Kayahara T, Kameya T, Kawai Y, et al. Recruited brown adipose tissue as an antiobesity agent in humans. J Clin Invest. 2013;123(8):3404–8. https://doi.org/10.1172/JCI67803.
Hanssen MJ, Hoeks J, Brans B, van der Lans AA, Schaart G, van den Driessche JJ, et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat Med. 2015;21(8):863–5. https://doi.org/10.1038/nm.3891.
Iwen KA, Backhaus J, Cassens M, Waltl M, Hedesan OC, Merkel M, et al. Cold-induced brown adipose tissue activity alters plasma fatty acids and improves glucose metabolism in men. J Clin Endocrinol Metab. 2017;102(11):4226–34. https://doi.org/10.1210/jc.2017-01250.
Nirengi S, Homma T, Inoue N, Sato H, Yoneshiro T, Matsushita M, et al. Assessment of human brown adipose tissue density during daily ingestion of thermogenic capsinoids using near-infrared time-resolved spectroscopy. J Biomed Opt. 2016;21(9): 091305. https://doi.org/10.1117/1.JBO.21.9.091305.
Nirengi S, Amagasa S, Homma T, Yoneshiro T, Matsumiya S, Kurosawa Y, et al. Daily ingestion of catechin-rich beverage increases brown adipose tissue density and decreases extramyocellular lipids in healthy young women. Springerplus. 2016;5(1):1363. https://doi.org/10.1186/s40064-016-3029-0.
Yoneshiro T, Matsushita M, Hibi M, Tone H, Takeshita M, Yasunaga K, et al. Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans. Am J Clin Nutr. 2017;105(4):873–81. https://doi.org/10.3945/ajcn.116.144972.
Yoshioka K, Yoshida T, Wakabayashi Y, Nishioka H, Kondo M. Reduced brown adipose tissue thermogenesis of obese rats after ovariectomy. Endocrinol Jpn. 1988;35(4):537–43. https://doi.org/10.1507/endocrj1954.35.537.
Blondin DP, Haman F, Swibas TM, Hogan-Lamarre S, Dumont L, Guertin J, et al. Brown adipose tissue metabolism in women is dependent on ovarian status. Am J Physiol Endocrinol Metab. 2024;326(5):E588–601. https://doi.org/10.1152/ajpendo.00077.2024.
Fuller-Jackson JP, Dordevic AL, Clarke IJ, Henry BA. Effect of sex and sex steroids on brown adipose tissue heat production in humans. Eur J Endocrinol. 2020;183(3):343–55. https://doi.org/10.1530/EJE-20-0184.
Herz CT, Kulterer OC, Prager M, Marculescu R, Langer FB, Prager G, et al. Sex differences in brown adipose tissue activity and cold-induced thermogenesis. Mol Cell Endocrinol. 2021;534: 111365. https://doi.org/10.1016/j.mce.2021.111365.
Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223–41. https://doi.org/10.1146/annurev-physiol-021115-105339.
Kliewer SA, Mangelsdorf DJ. A dozen years of discovery: insights into the physiology and pharmacology of FGF21. Cell Metab. 2019;29(2):246–53. https://doi.org/10.1016/j.cmet.2019.01.004.
Talukdar S, Zhou Y, Li D, Rossulek M, Dong J, Somayaji V, et al. A Long-Acting FGF21 Molecule, PF-05231023, Decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects. Cell Metab. 2016;23(3):427–40. https://doi.org/10.1016/j.cmet.2016.02.001.
Harrison SA, Frias JP, Neff G, Abrams GA, Lucas KJ, Sanchez W, et al. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Gastroenterol Hepatol. 2023;8(12):1080–93. https://doi.org/10.1016/S2468-1253(23)00272-8.
Hanssen MJ, Broeders E, Samms RJ, Vosselman MJ, van der Lans AA, Cheng CC, et al. Serum FGF21 levels are associated with brown adipose tissue activity in humans. Sci Rep. 2015;5:10275. https://doi.org/10.1038/srep10275.
Taniguchi H, Shimizu K, Wada S, Nirengi S, Kataoka H, Higashi A. Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial. J Physiol Anthropol. 2020;39(1):17. https://doi.org/10.1186/s40101-020-00226-w.
Badakhshi Y, Shao W, Liu D, Tian L, Pang J, Gu J, et al. Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21. Am J Physiol Endocrinol Metab. 2021;321(2):E292–304. https://doi.org/10.1152/ajpendo.00638.2020.
Hua L, Zhuo Y, Jiang D, Li J, Huang X, Zhu Y, et al. Identification of hepatic fibroblast growth factor 21 as a mediator in 17beta-estradiol-induced white adipose tissue browning. FASEB J. 2018;32(10):5602–11. https://doi.org/10.1096/fj.201800240R.
Allard C, Bonnet F, Xu B, Coons L, Albarado D, Hill C, et al. Activation of hepatic estrogen receptor-alpha increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice. Mol Metab. 2019;22:62–70. https://doi.org/10.1016/j.molmet.2019.02.002.
Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:92. https://doi.org/10.1186/1471-2288-13-92.
Nirengi S, Wakabayashi H, Matsushita M, Domichi M, Suzuki S, Sukino S, et al. An optimal condition for the evaluation of human brown adipose tissue by infrared thermography. PLoS ONE. 2019;14(8): e0220574. https://doi.org/10.1371/journal.pone.0220574.
Kataoka H, Nirengi S, Matsui Y, Taniguchi H. Fructose-induced FGF21 secretion does not activate brown adipose tissue in Japanese young men: randomized cross-over and randomized controlled trials. J Physiol Anthropol. 2024;43(1):5. https://doi.org/10.1186/s40101-023-00353-0.
Baker FC, Siboza F, Fuller A. Temperature regulation in women: effects of the menstrual cycle. Temperature (Austin). 2020;7(3):226–62. https://doi.org/10.1080/23328940.2020.1735927.
Fernandez-Pena C, Reimundez A, Viana F, Arce VM, Senaris R. Sex differences in thermoregulation in mammals: implications for energy homeostasis. Front Endocrinol (Lausanne). 2023;14:1093376. https://doi.org/10.3389/fendo.2023.1093376.
Tankersley CG, Nicholas WC, Deaver DR, Mikita D, Kenney WL. Estrogen replacement in middle-aged women: thermoregulatory responses to exercise in the heat. J Appl Physiol (1985). 1992;73(4):1238–45. https://doi.org/10.1152/jappl.1992.73.4.1238.
Brooks EM, Morgan AL, Pierzga JM, Wladkowski SL, O’Gorman JT, Derr JA, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol (1985). 1997;83(2):477–84. https://doi.org/10.1152/jappl.1997.83.2.477.
Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med. 2006;44(7):883–7. https://doi.org/10.1515/CCLM.2006.160.
Martinez de Morentin PB, Gonzalez-Garcia I, Martins L, Lage R, Fernandez-Mallo D, Martinez-Sanchez N, et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014;20(1):41–53. https://doi.org/10.1016/j.cmet.2014.03.031.
McIlvride S, Mushtaq A, Papacleovoulou G, Hurling C, Steel J, Jansen E, et al. A progesterone-brown fat axis is involved in regulating fetal growth. Sci Rep. 2017;7(1):10671. https://doi.org/10.1038/s41598-017-10979-7.
Chukijrungroat N, Khamphaya T, Weerachayaphorn J, Songserm T, Saengsirisuwan V. Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver. Am J Physiol Endocrinol Metab. 2017;313(2):E203–12. https://doi.org/10.1152/ajpendo.00076.2017.
Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al. Understanding weight gain at menopause. Climacteric. 2012;15(5):419–29. https://doi.org/10.3109/13697137.2012.707385.
Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes. 2010;59(11):2781–9. https://doi.org/10.2337/db10-0193.
Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246–53. https://doi.org/10.2337/db07-1476.
Taniguchi H, Tanisawa K, Sun X, Cao ZB, Oshima S, Ise R, et al. Cardiorespiratory fitness and visceral fat are key determinants of serum fibroblast growth factor 21 concentration in Japanese men. J Clin Endocrinol Metab. 2014;99(10):E1877–84. https://doi.org/10.1210/jc.2014-1877.
Taniguchi H, Tanisawa K, Sun X, Kubo T, Higuchi M. Endurance exercise reduces hepatic fat content and serum fibroblast growth factor 21 levels in elderly men. J Clin Endocrinol Metab. 2016;101(1):191–8. https://doi.org/10.1210/jc.2015-3308.
Kulzhanova D, Turesheva A, Donayeva A, Amanzholkyzy A, Abdelazim IA, Saparbayev S, et al. The cortisol levels in the follicular and luteal phases of the healthy menstruating women: a meta-analysis. Eur Rev Med Pharmacol Sci. 2023;27(17):8171–9. https://doi.org/10.26355/eurrev_202309_33577.
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–17. https://doi.org/10.1056/NEJMoa0810780.
Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, Schmadl M, et al. Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes. 2010;59(7):1789–93. https://doi.org/10.2337/db10-0004.
Ishida Y, Matsushita M, Yoneshiro T, Saito M, Fuse S, Hamaoka T, et al. Genetic evidence for involvement of beta2-adrenergic receptor in brown adipose tissue thermogenesis in humans. Int J Obes (Lond). 2024;48(8):1110–7. https://doi.org/10.1038/s41366-024-01522-6.
Glickman-Weiss E, Caine N, Cheatham CC, Blegen M, Scharschmidt T, Marcinkiewicz J. The effects of gender and menstrual phase on carbohydrate utilization during acute cold exposure. Wilderness Environ Med. 2000;11(1):5–11. https://doi.org/10.1580/1080-6032(2000)011[0005:teogam]2.3.co;2.
Add Comment